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Receptor  activation  of  phospholipase C (PLC) via G 
proteins  occurs by pertussis  toxin-sensitive  and  toxin- 
insensitive  signaling  pathways. The a-subunits of  the Gq 
family are presumed to mediate the toxin-insensitive 
pathway,  but  the  nature  of  the  G-proteins  mediating  the 
toxin-sensitive pathway is not established. Recently, 
PLC-p has  been  shown  to  be  activated  by  G-protein py- 
subunits  of  mixed  or  undefined  composition.  The  rela- 
tive  activities of  G-protein  subunits  that  might  activate 
PLC-p were  examined  using  defined  recombinant a- and 
/3ysubunits  obtained  from  the  baculovirus  expression 
system by reconstituting  the  purified  subunits  with  pu- 
rified  bovine  brain PLC-p1 or  turkey  erythrocyte PLC-p 
in unilamellar phospholipid vesicles. Turkey erythro- 
cyte Gall and  recombinant Gall and Gaq obtained  after 
expression in Sf9 cells activated both bovine brain 
PLC-p1 and  turkey  erythrocyte PLC-p. In contrast, un- 
der  the  same  assay  conditions,  recombinant  Gail, Gaia, 
Gais,  and Ga,, were  without  effect on either  type  of PLC. 
All types  of pysubunits  tested  (rp1y2, rp yS,  rpzy2,  rp2yS, 
bovine brain By or turkey erythrocyte py) inhibited 
Gall-mediated  activation of PLC, presumably  by  promo- 
tion of formation  of  inactive  heterotrimeric  G-protein. 
All types of pysubunits also markedly  stimulated  the 
activity of turkey  erythrocyte PLC-p but  did  not  activate 
bovine  brain PLC-p1. Of the  four  different Py complexes 
of  defined  composition,  three  stimulated PLC with  simi- 
lar activities  whereas pzys was less  effective. The  data 
suggest  that  pertussis  toxin-sensitive  activation of PLC 
is mediated  by  the flysubunits of  G-proteins  acting on 
specific  phospholipase C isoenzymes. 
Membrane  receptors for a large  number of neurotransmit- 
ters, hormones, and growth factors  activate phospholipase C 
leading  to  the breakdown of PtdIns(4,5)Pz1 and  generation of 
the  intracellular  messengers inositol 1,4,5-trisphosphate and 
diacylglycerol (1). Much diversity exists among the proteins 
comprising the transmembrane signaling mechanisms that 
generate  these two messages. The phospholipase C enzymes 
Grants GM-29536, GM-38213,  and  DK-19952.  The costs of publication 
* This work was supported by United States Public Health Service 
of this article  were defrayed in part by the payment of page  charges. 
This article  must  therefore be hereby marked “aduertisement” in ac- 
cordance  with 18 U.S.C.  Section  1734  solely  to  indicate this fact. 
5 These authors  contributed  equally to  this work. 
ogy, CB 7365, Faculty  Laboratory Office Bldg.,  UNC-CH  School of Medi- 
11 To whom  correspondence  should be addressed: Dept. of Pharmacol- 
cine,  Chapel  Hill, NC 27599-7365.  Tel.: 919-966-4816. 
** Present address: Dept. of Pharmacology & Toxicology, P.O. Box 
9223 HSN, West Virginia  University,  Morgantown, WV 26506-9223. 
The  abbreviations  are:  F’tdIns(4,5)P2,  phosphatidylinositol  4,5- 
bisphosphate;  GTPyS,  guanosine 5’-3-O-(thiotriphosphate); DTT, 
dithiothreitol; CHAPS, 3-[(3-cholamidopropyl)dimethylammoniol-1- 
propanesulfonic acid; PLC,  phospholipase C. 
include three major  families comprised of the p, y, and 8 iso- 
forms (2). Most growth  factor  receptors with  intrinsic tyrosine 
kinase activity phosphorylate phospholipase C--y on tyrosine 
residues  leading  to  recruitment of this  protein  to a membrane 
signaling complex (3-5). In  contrast,  the p-isoforms of phospho- 
lipase C are  regulated by certain members of the  large family of 
heterotrimeric G-proteins through two different mechanisms 
(5, 6). The most  ubiquitous of these is pertussis toxin-insensi- 
tive, while a less prominent  pathway is inactivated by treat- 
ment of cells with  pertussis toxin (7). 
I t  is now clear  that  the toxin-insensitive  mechanism is me- 
diated by the  a-subunits of the recently discovered G, family of 
G-proteins (6). Experiments performed with purified proteins 
have demonstrated that the a-subunits of  G, and GI1 can 
stimulate the phospholipase C-/3 isoenzymes (8-12). Similar 
conclusions have been  reached in  experiments  using  cultured 
cells transfected  with cDNAs coding for the  a-subunits of mem- 
bers of the G, family (13, 14). Thus,  the mechanism by which 
G, activates phospholipase C-/3 appears  to follow the well es- 
tablished model for G-protein-linked systems in which hor- 
mone-activated  receptors  promote release of an  activated 
a-subunit, which then directly stimulates  the effector protein 
(15). 
The pertussis toxin-sensitive mechanism for activation of 
phospholipase C is less well understood. The major evidence 
that a member of the Gi family of G-proteins  may be involved is 
that receptor-promoted  activation of phospholipase C in some 
cells and by certain receptors is inhibited by pretreatment of 
cells with pertussis toxin (7, 16-19). The fact that only the 
three Gi and  the Go a-subunits  have  sites for ADP-ribosylation 
by pertussis toxin  implicates these proteins in coupling recep- 
tors to activation of phospholipase C. However, there is no 
direct evidence that phospholipase C can be activated by a-sub- 
units of Gi or Go. While it could be argued that an unknown 
a-subunit  or phospholipase C isoenzyme might  be responsible 
for the observed toxin sensitivity, the recent discovery that 
G-protein  &-subunits can  activate phospholipase C suggests 
an  alternative mechanism (20-22). Thus,  heterotrimeric Gi or 
Go could be  activated by receptor occupation and  release its 
py-subunits, and  the  py-subunits could stimulate  the effector, 
phospholipase C. The existence of four  different  forms of G- 
protein p-subunits  and  up to seven forms of y-subunits  makes 
this a potentially complex system (61, since &subunit  dimers 
formed from  different  combinations of p and y might differen- 
tially  stimulate  the phospholipase C isoenzymes. 
“he  present work was  carried  out to answer two questions 
regarding  the activation of phospholipase C by G-protein a- and 
by-subunits. First, considering the pertussis toxin-sensitive 
pathway, can purified Gi and Go a-subunits  activate various 
forms of phospholipase C reconstituted into phospholipid 
vesicles under conditions  where these enzymes are  markedly 
activated by members of the G, family? Second, can G-protein 
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&-subunits of defined  composition activate purified isoforms of 
phospholipase C  and are  there differences  between their capac- 
ity to activate the phospholipase C isoforms? These questions 
were approached using purified bovine brain  PLC-pl  and  tur- 
key erythrocyte PLC-p activated by different purified recombi- 
nant G-protein a- and py-subunits. The results suggest that  the 
Gi and Go a-subunits are incapable of activating  either form of 
phospholipase C, that phospholipase C-pl and the turkey 
erythrocyte PLC-p differ in  their capacity to be activated by 
fly-subunits, and that certain combinations of the py-subunits 
activate the turkey erythrocyte phospholipase C-p  more effec- 
tively than other fly-complexes. 
EXPERIMENTAL PROCEDURES 
Purification ofNatiue py-Subunits-Gprotein pysubunits were re- 
solved  from purified bovine brain GJGi in  the presence of  AlCl,,  NaF, 
and MgC12 as described (23). Gprotein py-subunits also were purified 
from turkey erythrocyte plasma membranes under non-activating con- 
ditions as we have reported (23). The properties of both preparations of 
py-subunits have been described in detail (21,23). 
Purification of Phospholipase C-Phospholipase C from turkey 
erythrocytesz was purified to homogeneity  from the cytosolic fraction of 
turkey erythrocytes as previously  described  (24). The properties of this 
150-kDa polyphosphoinositide-specific phospholipase C have been  de- 
scribed in detail (21, 24, 25). Phospholipase C-pl was purified from 
bovine brain by the method of Lee  et al. (26) as previously  described 
(21). The possibility of the presence of contaminant G-protein a-sub- 
units in  the phospholipase C and  Bysubunit preparations was ruled out 
by: ( a )  silver staining of gels &r SDS-polyacrylamide  gel electropho- 
resis; (b) lack of [36SIGTPyS binding activity, and  (c) lack of immuno- 
reactivity against  a-subunit common antibodies and Ga, and Gall anti- 
peptide antibodies (data not shown). 
Purification of Ga,-The 42-kDa protein confemng AlF, activation 
to phospholipase C was purified from cholate extracts prepared from 
turkey erythrocyte plasma membranes as previously  described in detail 
(12). This protein has been identified as Gal,, based on complete  ho- 
mology  of partial  internal amino acid sequence of the purified protein 
with the sequence predicted from avian Gall cDNA (27). The avian 
protein sequence is 98%  homologous to mammalian Gall sequence. 
Expression and Extraction of Recombinant Ga,, and Ga,+fS cells 
were infected at a multiplicity of infection of 1:l for Gall  and 3:l for Ga, 
with the corresponding viral stock as previously  described (27,28). Cells 
were harvested after 72 h and washed twice with ice-cold phosphate- 
buffered isotonic NaCl, pH  7.5. Cells were  homogenized in 1 m~ 
NaHCO,, 5 m~ MgCl,,  10 m~ Tris, pH  7.2. After centrifugation at  500 
x g ,  the  supernatant was collected and centrifuged at  100,000 x g for  30 
min at 4 "C. The membrane pellet was resuspended with 20 m~ Tris, pH 
7.4, 1 m~ DTT,  10 m~ MgCl2, 10 m~ NaF,  20 p AlCl,, 0.1 m~ benza- 
midine and 0.1 m~ phenylmethylsulfonyl fluoride. Ten percent cholate 
was added to the suspension to obtain 1.2% final concentration. The 
suspension was stirred for  30 min at 4 "C and centrifuged at  100,000 x 
g for 30 min. Membrane extracts were  collected and used without fur- 
ther purification in reconstitution experiments. 
Expression and Purification of recombinant Gail, Ga, GaiB and 
The identity of the turkey erythrocyte phospholipase C is not clear 
because cDNA encoding  for this protein has not been  cloned.  However, 
substantial  internal amino acid sequence has been obtained from the 
purified protein. Ten peptides ranging in length from 6 to 20 amino 
acids have an overall identity to rat phospholipase C-pl, human phos- 
pholipase C+2, and  human phospholipase C-p3 of 51, 70, and 521, 
respectively (G.  L.  Waldo and T. K. Harden, unpublished data). We have 
cloned  cDNAencoding  for turkey phospholipase C-61, and  the predicted 
sequence is >90%  homologous to that of rat phospholipase C-pl (A. J. 
Morris and T. K. Harden, unpublished data). This suggests to us that, 
although the avian protein may be  more like phospholipase  C-p2 than 
phospholipase C-pl or phospholipase C-p3, it is probably an additional 
phospholipase C-p type, since based on the high homology between 
avian and rat phospholipase C-pl we would expect a similar level of 
homology between avian and human homologues of phospholipase 
C-02. In support of this idea, the purified avian phospholipase C does 
not react with an antisera generated against a carboxyl-terminal se- 
quence from phospholipase C-p2. This antisera strongly reacts with 
recombinant phospholipase C-p2. In addition, the turkey erythrocyte 
lipase C-pZ during SDS-polyacrylamide  gel electrophoresis. 
phospholipase C comigrates with phospholipase C-pl but not phospho- 
G%-The a-subunits of the proteins Gil, Giz, Gi3, and Go were expressed 
using the baculovirua expression system as described  (28). The recom- 
binant G-protein a-subunits were purified to homogeneity using DEAF,, 
hydroxyapatite, and Mono P chromatography as described  (28). 
Expression and Purification of Recombinant  py-Subunits-SfS  cells 
were infected with the appropriate recombinant baculoviruses, cul- 
tured,  and harvested exactly as previously  described (29). Frozen, har- 
vested cells were thawed in 15 times their wet weight of ice cold ho- 
mogenization  buffer (consisting of 10 m~ Tris, pH 8.0 at 4 "C, 25 m~ 
NaCl, 10 m~ MgClZ, 1 m~ EGTA, 1 m~ DTT, 0.1 m~ phenylmethylsul- 
fonyl fluoride, 20 pg/ml benzamidine, and 2 pg/ml each of aprotinin, 
leupeptin, and  pepstatin A) and  burst by  Nz cavitation after equilibra- 
tion at 600 p.8.i. for 20 min. Lysed cells were mixed with an equal 
volume of homogenization  buffer containing twice the desired final con- 
centration of detergent and gently stirred for 1 h at  4 "C. Cholate (l%, 
w/v, final concentration), octylthioglucoside (Pierce, 1.1 or 0.4%, w/v) 
and Genapol  C-100  (Calbiochem, 0.1%,  w/v)  proved equally effective for 
solubilization of the recombinant By dimers and behaved similarly in 
subsequent steps of purification. Genapol C-100 was chosen for the 
standard protocol. The detergent extract was centrifuged at 100,OOO x g 
for 1 h, filtered through a 0.45-pm membrane, and applied at a flow rate 
of 5 mYmin to a 2 x 10-cm  DEAE HRAO (Waters) column equilibrated 
(w/v), pH 8.0 at 4°C.). The flow rate was reduced to 3 d m i n ,  the 
column was washed with 36 ml(-2 column  volumes) of TEDKHAPS, 
and eluted with a 96-ml linear gradient from 0 to 300 m~ NaCl in 
TED/CHAPS. The bulk of the recombinant By dimers consistently 
eluted between 90 and 180 m~ NaC1. These fractiona were pooled and 
used for affinity purification of the recombinant By dimers using G- 
protein a-subunits immobilized  on agarose beads. 
Synthesis of the Gaiz aiiinity matrix was essentially as developed  by 
Pang and Sternweis (30) and described by  Mumby et at. (31). Briefly, 
waminobutylagarose (Sigma, A-6142) was washed with 50 m~ sodium 
phosphate, pH  7.0, and mixed with an equal volume of the same buffer 
containing 0.25 m~ m-maleimidobenzoyl-N-hydroxysulfosuccinimide 
ester (Pierce Chemical Co.). After purging with N2, the mixture was 
incubated for  30 min at  room temperature  and washed twice with 10 ml 
of phosphate buffedml of resin. Purified recombinant Gail (2.85 mg), 
prepared as described  (28), was reduced in the presence of 1 m~ DTT 
and 5 p~ GDP and exchanged into thoroughly degassed  200 m~ KPO,, 
200 m~ NaCl, 5 p~ GDP, 0.05% Genapol C-100, pH 8.0, using an 
HR10/10 Fast Desalting column (Pharmacia). The protein solution (-2 
ml )  was mixed with 1.5 ml of the activated resin, and  the tube was 
purged with argon, sealed, and tumbled slowly  for 1 h at 4 "C. After the 
coupling reaction, the resin was washed with 5 volumes of 50 m~ NaPO, 
(pH 71, 1 m~ EDTA, 300 m~ NaCl, 2 p GDP, 0.1% Genapol C-100, 
followed  by 5 volumes of the same buffer containing 50 m~ p-mercap- 
toethanol. The resin was stored in 50 m~ HEPES (pH 8.0), 100 m~ 
NaCl, 1 m~ EDTA,  0.1% Genapol  C-100, 30% glycerol, 1 m~ Dm, and 
5 p GDP at 4 "C (storage buffer). 
HEPES (pH 8.0), 1 m~ EDTA, 200 m~ NaCl, 0.6% CHAPS, 3 m~ Dm, 
The affinity resin was washed prior to  use with 10 volumes of 20 m~ 
5 p GDP (wash buffer). GDP was added to the pooled  DEAE fractions 
to  a final concentration of 5 p ~ ,  the DEAE pool was mixed with the 
affinity resin,  and the mixture was gently tumbled for 1 h at  4 "C. 
Following a gentle centrifugation (50 x g, 5 min), the resin was resus- 
pended in 10 ml of wash buffer and poured into a Poly-Rep column 
(Bio-Rad). The bed was washed twice with 2 ml of wash buffer, and 
twice with 2 ml of wash buffer with 400 m~ NaCl (final concentration). 
For elution of the recombinant By dimers, 1 ml  of elution buffer (20 m~ 
HEPES, pH 8.0, l  m~ EDTA, 200 m~ NaCl,  50 m~ MgClZ, 10 m~ NaF, 
30 p 3 m~ DTT, 5 p GDP, 0.6% CHAPS) was passed over the 
resin, flow was stopped, and an additional 2 ml of elution buffer was 
placed  on the column and allowed  to stand for 15 min. After collecting 
the first 2-ml fraction, an additional 6 ml  of elution buffer was passed 
over the resin, the fractions pooled, concentrated to 0.1-0.5  mg/ml with 
a Centricon 30 (Amicon), aliquoted, and stored at -70 "C until use. The 
resin was then washed with 20  ml  of wash buffer and placed in storage 
buffer  (above). 
Reconstitution and PLC Assay-G-protein a- and py-subunits were 
reconstituted into lipid  vesicles by removal of detergent as dewxibed 
(21). Briefly, [3H1PtdIns(4,5)Pz, phosphatidylethanolamine, and phos- 
phatidylserine were combined in a 1:41 molar ratio, and phospholipids 
were dried under a stream of nitrogen and resuspended to 100 p 
[3HlPtdIns(4,5)Pz (specific activity 10.000 cpminmol) by sonication in a 
medium containing 20 m~ Hepes,  pH 7.4,l m~ MgClZ, 100 m~ NaCl, 2 
m~ Dm, 0.1 m~ benzamidine, and 0.8% sodium cholate. Gprotein a- 
and/or py-subunits were  combined with detergent-resuspended phos- 
with TED/CHAPS (50 m~ Tris-C1, 1 m~ EDTA, 1 m~ D", 0.6%  CHAPS 
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FIG.  1. Effect of recombinant Gpro- 
tein a-subunits on phospholipase C 
activity. Phospholipid vesicles contain- 
ing the indicated concentrations of puri- 
fied Gall (circles), rG% (diamonds), rGa,* 
(inverted triangles), r G q Z  (squares),  and 
&ai3 (triangles) were prepared as de- 
and incubated for 15 min at  30 "C in the 
scribed under 'Experimental Procedures" 
presence of two Merent isoforms of puri- 
fied phospholipase C. Lef? panel, G-pro- 
tein  a-subunits with 10 ng of turkey 
erythrocyte phospholipase  C-p; right 
panel, G-protein a-subunits with 10 ng of 
bovine brain PLC-p1. Data shown are 
from  one experiment repeated three times 
with similar results. 
d 
pholipids and dialyzed for 16-20 h against the same buffer without 
cholate. This preparation consists of unilamellar vesicles of 60-120 nm 
diameter. Phospholipid vesicles were diluted 2.5-fold with dialysis 
buffer and phospholipase C assays were carried out as previously  de- 
scribed in detail (21). with the following  modifications: fatty acid-free 
BSA was used instead of  BSA Fraction V, and the final concentration of 
free Ca2+ was increased to 3 p ~ .  Reactions were started by the addition 
of 5-10 ng of phospholipase C and were terminated by extraction of 
phospholipids as previously  described (21). [3HlIns(1,4,5)P3 released to 
the aqueous phase was quantitated by scintillation spectroscopy. Under 
these conditions  phospholipase C activity was linear for up to 15 min 
and less than 20-25%  of substrate was  hydrolyzed. 
Data Presentation-Most of the figures are of data from representa- 
tive experiments. The data presented are  the mean or the mean S.D. 
from determinations in triplicate from experiments repeated at least 
three times using different vesicle preparations. S.D. was less than 10% 
of the mean for all data points. 
Materials-PtdIns(4,5)PZ was purified from a lipid extract obtained 
from  bovine brain (type I Folch fraction obtained from Sigma). 
[SHlPtdIns(4,5)Pz was prepared from  [SHlinositol-labeled turkey eryth- 
rocytes as described (24). Phosphatidylethanolamine from  bovine heart 
and phosphatidylserine from  bovine brain were obtained from  Avanti 
Polar Lipids, Inc. [SHIInositol  (20  Ci/mmol) was from  American  Radio- 
labeled Chemicals Inc.  All other reagents were  from  sources cited pre- 
viously  (21,  23,  28,  29). 
RESULTS 
To examine selectivity of activation of phospholipase C-p 
class isoenzymes, unilamellar [3HlPtdIns(4,5)P2-containing 
phospholipid  vesicles were reconstituted with various amounts 
of G-protein a-subunits  and with purified turkey erythrocyte 
phospholipase C-p2 or phospholipase C-pl. Reconstitution of up 
to 300 ng of recombinant Gail, Gaiz, Gaia or Ga,  did not alter 
basal activity or confer AlF;-stimulated activity to either of the 
phospholipase C isoenzymes  (Fig. 1). Although these recombi- 
nant proteins did not stimulate phospholipase C, they are  as 
active as native proteins in  other  assays of activity (28). As we 
have reported previously (12, 21), reconstitution of purified 
turkey erythrocyte Gall under the same conditions resulted  in 
marked AlF;-promoted stimulation of both turkey erythrocyte 
phospholipase C-p and phospholipase C-pl (Fig. 1). The appar- 
ent affinity for Gall and the maximal stimulation observed 
were very similar for each phospholipase C-p isoform.  Recon- 
stitution of baculovirus-expressed Gall  and Ga, also conferred 
marked AlF;-stimulated activity to phospholipase C-pl and  the 
turkey erythrocyte enzyme  (Fig. 2). Thus, whereas Gall  and 
TE PLC 
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Ga, markedly activate phospholipase C-p family  isoenzymes, 
a-subunits of Gi or Go apparently are not regulators of these 
effectors under the same assay conditions. 
The lack of a direct effect of Gai or Ga,  on phospholipase C 
activity, together with the recent reports of marked stimulation 
of inositol lipid hydrolysis by G-protein py-subunits (20-221, 
suggests that  the release of py-subunits from heterotrimeric 
G-proteins accounts for pertussis toxin-sensitive inositol lipid 
signaling. Using expressed and purified py-subunits of defined 
composition, we compared the activities of these proteins with 
purified py-subunits from bovine brain or turkey erythrocytes. 
As illustrated  in  the silver-stained gel  shown in Fig. 3, the four 
purified recombinant py-subunit combinations all were essen- 
tially free of contaminating proteins.' 
It was important to test  the functionality of the recombinant 
py-dimers relative to the activity of native bovine brain or 
turkey erythrocyte py-subunits. Gall-mediated stimulation of 
phospholipase C is inhibited by  low concentrations of Py-sub- 
units, presumably due to formation of inactive heterotrimeric 
Gll rather  than by a direct effect of py-subunits on phospholi- 
pase C (12, 21). Therefore, the effect of the recombinant py- 
dimers on Gall-mediated activation of phospholipase C was 
examined. As illustrated in Fig. 4, all four recombinant py- 
dimers inhibited Gall-activated phospholipase C-pl with simi- 
lar potency and efficacy. Similar effects  were  observed  when the 
turkey erythrocyte phospholipase C-p was used instead of 
phospholipase C-pl (data not shown). All of the recombinant 
py-dimers used in  this study were equally active in supporting 
pertussis toxin-induced ADP ribosylation of Gai-subunits4 and 
in conferring high affinity binding characteristics to expressed 
adenosine receptors (32). It has been  previously reported that 
the ?,-subunit expressed in Sf9 cells incorporates [3Hlmevalo- 
nate  and  is carboxymethylated and therefore is likely to have 
undergone appropriate post-translational modification of the 
carboxyl terminus (29, 33). The fact that  the recombinant py- 
dimers were purified by affinity chromatography on a Gpro- 
tein  a-subunit column is also consistent with this idea, since 
The turkey erythrocyte By preparation consists predominantly of 
turkey erythrocyte preparation shown in Fig. 3. The bovine brain prepa- 
PI-, pz-, and y,-subunits. ps, y2, ys, and ys were not detectable in the 
ration consists of p l  and p2 and a mixture of four y-subunits (21). 
S. G. Graber and J. C. Garrison, unpublished observations. 
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FIG. 2. Activation of phospholipase C isoenzymes  by  recombi- 
nant Gall and G%. Phospholipid vesicles containing purified turkey 
erythrocyte Gall (TE Gall), recombinant Gall ( rGal l ) ,  or recombinant 
Ga, (rGa,) were prepared as described under "Experimental Proce- 
dures" and incubated for 15 min at  30 "C with 10 ng of either turkey 
erythrocyte phospholipase C-p (TE PLC) or purified bovine brain phos- 
pholipase C-pl (PLC pl). Incubations were in the absence (vehicle, 
filled bars) or  in  the presence (empty  bars) of  AIF;. Results shown are 
the mean of duplicate assays from a representative experiment re- 
peated at  least  three times  using different phospholipid vesicle prepa- 
rations. 
non-prenylated  py-dimers do not associate  tightly with a-sub- 
units (34). I t  also has been reported that recombinant Py- 
dimers purified after expression in Sf9 cells modulate adenylyl 
cyclase activity with  properties  similar  to  those previously ob- 
served with preparations of native py-subunits (34). Thus, 
based on a broad range of criteria,  the purified  recombinant 
py-subunits of defined composition possess the full  complement 
of activities of their  native  dimer  counterparts. 
The  relative capacities of the purified py-subunits of defined 
composition to activate phospholipase C were examined. Al- 
though  the concentrations required were 30-fold higher  than 
for the inhibition of Gall-stimulated phospholipase C, all four 
recombinant &-dimers directly activated  turkey  erythrocyte 
phospholipase C-p with a potency similar to that observed with 
bovine brain f ly (Fig. 5 A )  or turkey  erythrocyte  py-subunit  (not 
shown). It is  important to stress  that  all of the  stimulating 
effects of py-subunits on phospholipase C occurred in  the ab- 
sence of any  a-subunit. As indicated in Fig. 5A, the p2y3 dimer 
consistently produced a sub-maximal  activation of turkey 
erythrocyte  phospholipase C-p when compared with  the effi- 
cacy of the  other py-dimers or with the bovine brain  py-subunit 
preparation.  Similar  results were observed with two different 
preparations of purified P2y3-subunit. Based on immunoblot- 
ting of the phospholipid vesicle preparations,  the  amount of 
P2y3-subunit added  in  these  experiments  was  the  same as the 
amount of the  other &dimers (not shown). Furthermore,  the 
similar activity of all  four  py-dimer  combinations for reversal of 
Gall-stimulated enzyme  activity and  in  other tests of function- 
ality  suggests  that  the low efficacy of p2y3 for activation of 
phospholipase C is not caused by expression of an  "inactive" 
dimer combination. Thus, some selectivity may exist among 
various  py-dimers for activation of phospholipase C. In  contrast 
to the effect of the  py-subunits on turkey erythrocyte phospho- 
lipase C-p, none of these  preparations  activated phospholipase 
C-pl at concentrations of py-subunit up to 300 ng/assay. Under 
the  same  assay conditions, AlFi-activated Gall produced simi- 
lar  increases  in  the activity of both the  turkey erythrocyte and 







RG. 3. SDSpolyacrylamide  electrophoresis of purified Gpro- 
tein flysubunits. One hundred ng of purified turkey erythrocyte By 
(lane I), recombinant plyz (lane 2) ,  recombinant ply3 (lane 3), recom- 
binant pZyz (lane 4 ) .  recombinant pzy3 (lane 51, purified bovine brain Py 
(lane 6 ) ,  and turkey erythrocyte py (lane 7) were subjected to electro- 
phoresis on a 10-20% polyacrylamide gradient gel containing 6 M urea 
indicated on the left. The double bands with molecular sizes of about 68 
and  stained with silver. The mobility of the molecular mass  markers is 
kDa are  artifads of the silver-staining technique. 
." 
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FIG. 4. Effect of recombinant flysubunite on Gall activation of 
phospholipase C. Phospholipid vesicles containing 15 ng of Gall and 
the indicated concentrations of bovine brain or recombinant py-sub- 
units were prepared as indicated under "Experimental Procedures." 
Lipid vesicles were incubated for 15 min a t  30 "C with 10 ng of PLC-pl 
in  the absence (open symbols) or in  the presence (filled symbols) of 
AIF;. Results shown are  the mean 2 S.D. of data obtained in one  ex- 
periment  carried  out in triplicate,  and repeated three times with similar 
results. 
DISCUSSION 
The  marked progress in  understanding receptor-regulated 
inositol lipid signaling has been primarily restricted to the 
pathways involving receptor-promoted activation of the G, 
family of G-proteins and tyrosine phosphorylation of phospho- 
lipase C-y. Although sensitivity to inactivation by pertussis 
toxin led to the  idea  that Go or a form of Gi is involved in 
regulation of phospholipase C by a subset of receptors, e.g., 
fMetLeuPhe  receptors in  neutrophils (7), neither  the protein 
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turkey erythrocyte and bovine brain 
FIG. 5. Differential activation of 
phospholipases C by purified and re- 
combinant Gprotein flysubunits. 
Phospholipid  vesicles  containing the indi- 
cated concentrations of G-protein sub- 
units were prepared as indicated under 
'Experimental Procedures." Left panel, 
lipid  vesicles  containing the  indicated 
bated with 10 ng of turkey erythrocyte 
concentrations of Bysubunits were incu- 
phospholipase C-p (filled  symbols) or 
with 10 ng of bovine  brain  PLC-p1 (open 
symbols). Right panel, lipid vesicles con- 
taining Gall were incubated in the ab- 
sence (filled  bars) or in the presence of 
AlF, (open bars). Incubations were for 15 
min at 30 "C. Data  shown are the mean * 
S.D. from one experiment performed in 
triplicate and repeated at least six times 
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components of this pathway nor the mechanism of their  inter- 
action have been unambiguously identified. It has been tacitly 
assumed that activation of phospholipase C occurs by receptor- 
promoted release of a GTP-liganded  form of Gai or Ga,.  How- 
ever, direct support for this idea is limited to evidence support- 
ing a role  for  Ga, in receptor-regulated inositol lipid signaling 
in frog  oocytes (35). 
The data reported here illustrate  that purified recombinant 
Gail, Gaiz, Gai3, and  Ga, have no effect  on the activity of two 
different G-protein-regulated phospholipase C isoenzymes. 
These G-protein a-subunits are as active as native protein in 
tests of their capacity to interact with G-protein py-subunits4 
or to promote high affinity binding of agonists to adenosine 
receptors (32)  and angiotensin receptors (28). Thus, two  phos- 
pholipase C-p family isoenzymes that  are markedly activated 
by Gail  and  Gaq are not activated by the  pertussis toxin-sen- 
sitive a-subunits  extant.  Our  results do not rule out the possi- 
bility that other phospholipase C isoenzymes exist that  are 
activated by these a-subunits; they also do not address the 
potential existence of yet to be identified pertussis toxin-sensi- 
tive a-subunits. However, these  data, together with results  re- 
ported by others indicating that various forms of Gi or Go  do not 
stimulate phospholipase C under conditions where members of 
the G, family are very active (8-11), strongly support the idea 
that a-subunits of pertussis toxin-sensitive G-proteins are not 
important direct activators of phospholipase C. 
The data reported here with recombinant py-subunits of 
various and defined composition are consistent with reports by 
this  and other groups indicating that G-protein py-subunits are 
effective activators of some members of the phospholipase C 
family. The most parsimonious interpretation of these  results is 
that pertussis toxin-sensitive inositol lipid signaling occurs as 
a consequence of receptor-promoted dissociation of  Go or a form 
of Gi into free a- and py-subunits. The py-subunit then acti- 
vates phospholipase C. Very few studies have been reported 
examining the effect of py-subunits on phospholipase C in  in- 
tact cells or membranes. Katz et al. (36) have recently reported 
that cotransfection of Cos-1 cells with py-subunit and phospho- 
lipase C-p2 resulted  in a marked increase in inositol phosphate 
accumulation, and that cotransfection of Mz-muscarinic recep- 
tors and Gaiz in  these cells resulted  in carbachol-stimulated 
inositol phosphate production that was inhibited by treatment 
of cells with pertussis toxin. It will be important  to obtain more 
information on direct involvement of py-subunits in  this  path- 
way in cells not over-expressing large amounts of signaling 
components. 





bovine brain  and  turkey erythrocytes (21), four different recom- 
binant py-subunits markedly activated the avian phospholi- 
pase C but  had essentially no  effect on  bovine brain phospho- 
lipase C-pl under the same conditions. The maximal activity 
observed with the  avian phospholipase C in these studies was 
at least as large as that observed with maximally effective 
concentrations of Gall. Thus, whereas direct regulation of the 
avian enzyme by py-subunits is likely to be important, this 
seems much less likely with the phospholipase C-pl isoenzyme. 
Park et al. (37) and Smrcka and Sternweis (38) also reported 
that  pysubunit activated phospholipase C isoenzymes with the 
relative order of p3 > p2 > pl. Similarly, Carozzi et al. (39) 
recently have reported that under conditions where phospholi- 
pase C-pl is marginally activated by transducin py-subunit, 
purified phospholipase C-p3 is markedly activated. Results 
from  two recent reports studying the relative activities of phos- 
pholipase C-pl  and phospholipase C-p2 overexpressed in Cos 
cells are consistent with our  results using purified proteins. 
Thus, Katz  et al. (36) observed selectivity of activation by  co- 
expressed plyi-subunit of phospholipase C-p2  over  phospholi- 
pase C-pl. Similarly, Camps and co-workers (40) reported that 
reconstitution of transducin py-subunit into membranes pre- 
pared from Cos cells overexpressing phospholipase C-p2 re- 
sulted in a higher enzyme activity than reconstitution into 
membranes containing overexpressed phospholipase C-pl. 
The full significance of py-subunit regulation of phospholi- 
pase C is not yet established. Although it is possible that py- 
subunit released from members of the Gq family  could under 
certain  situations  activate phospholipase C in a physiologically 
important way, this does not appear to be an effect of major 
importance. The apparent affinity of Gall for activation of the 
avian phospholipase C used in  these  studies  is approximately 
30-fold greater  than  the corresponding affinity of py-subunit 
for activation. Furthermore, py-subunits in stoichiometric con- 
centrations with Gail decrease rather  than promote  phospho- 
lipase C activity, apparently due to formation of inactive het- 
erotrimeric Gl1. However, it is also true  that some 
phospholipase C-p isoenzymes, e.g. ,phospholipase C-p2, are 
less sensitive to activation by  Ga, and  Gall (411, and  in cells 
expressing this  but not other isozymes, regulation of inositol 
lipid signaling could potentially occur through activation by 
py-subunits. It also is possible, as  has been suggested by the 
results of Blank et al. (22), that phospholipase C isoenzymes 
exist that  are activated by pysubunits  but not by G-protein 
a-subunits. 
A potential role for py-subunit-mediated activation of phos- 
pholipase C in pertussis toxin-sensitive inositol lipid signaling 
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is more clear-cut for the reasons discussed earlier. Additionally, 
the amount of Gi and Go in  target  tissues i relatively high with 
the extreme case that for Go in brain where this G-protein 
accounts for up to 2% of total membrane protein. Thus,  the 
potential exists for receptor-promoted releases of large 
amounts of py-subunit from these toxin-sensitive G-proteins. 
Release of py-subunit from G-proteins that  are not pertussis 
toxin substrates also might have important signaling conse- 
quences. For example, G,, in which no phospholipase C-stimu- 
lating activity is known to reside in the a-subunit, could  con- 
ceivably activate phospholipase C through release of f ly- 
subunit. In this regard, it is of interest that activation of 
P-adrenergic receptors in turkey erythrocyte membranes re- 
sults  in an increase in inositol lipid hydrolysis (42, 43). 
One of the principle hypotheses tested in the  current work 
was the idea that py-subunits of differing composition would 
have differing activities for stimulation of phospholipase C. 
This was the case  for  only  one of the  subunits tested here, p2y3, 
which was clearly less active for stimulation of phospholipase C 
than  it was in  other  tests of activity. This result potentially 
could  be a  harbinger of even larger differences in activity of yet 
to be tested fly-dimers, or in tests of P2y3-subunit with other 
phospholipase C isoenzymes. It should be noted that activation 
of phospholipase C by transducin py-subunit only  occurs at 100 
to 1000-fold higher concentrations of transducin py-subunit 
(20) than  the activating concentrations of py-subunit in  the 
current study. 
In summary, the results reported here with purified compo- 
nents strongly favor the idea that receptor-promoted dissocia- 
tion of pertussis toxin-sensitive G-proteins results in activation 
of phospholipase C through the release of py- rather than 
a-subunits. Our results do not indicate major differences in 
activity of py-subunits of differing composition.  However,  lower 
activity of the p2y3-subunit together with the fact that phos- 
pholipase C-pl is markedly activated by Gall, but not by P-y- 
subunits, suggests that  it will  be crucial to delineate the rela- 
tive activity of all possible py-dimers and to establish their 
existence as authentic dimers in mammalian cells. The prop- 
erties of the inositol lipid response of an individual cell to ex- 
tracellular ligands will not only depend on the complement of 
cell surface receptors, but also on the G-protein a-, p-, and 
y-subunits and phospholipase C isoenzymes that  are ex- 
pressed. An important  step  in molecularly defining receptor- 
regulated inositol lipid signaling pathways will  be to identify 
all of the G-proteins and phospholipase C isoenzymes that exist 
in a given homogeneous cell and to define the specificity of 
interaction of these components during activation of receptors 
that signal through pertussis toxin-sensitive and insensitive 
components. 
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